These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 15548679)
1. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Miotto E; Sabbioni S; Veronese A; Calin GA; Gullini S; Liboni A; Gramantieri L; Bolondi L; Ferrazzi E; Gafà R; Lanza G; Negrini M Cancer Res; 2004 Nov; 64(22):8156-9. PubMed ID: 15548679 [TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer. Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143 [TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117 [TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma. Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668 [TBL] [Abstract][Full Text] [Related]
6. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180 [TBL] [Abstract][Full Text] [Related]
8. A cancer-prone case with a background of methylation of p16 tumor suppressor gene. Hibi K; Koike M; Nakayama H; Fujitake S; Kasai Y; Ito K; Akiyama S; Nakao A Clin Cancer Res; 2003 Mar; 9(3):1053-6. PubMed ID: 12631606 [TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. Wen XZ; Akiyama Y; Baylin SB; Yuasa Y Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers. Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146 [TBL] [Abstract][Full Text] [Related]
13. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma]. Zhou YN; Xu CP; Han B; Ji R Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136 [TBL] [Abstract][Full Text] [Related]
14. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of the CHFR gene in digestive tract cancer. Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108 [TBL] [Abstract][Full Text] [Related]
16. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
17. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines. Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512 [TBL] [Abstract][Full Text] [Related]
18. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer. Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792 [TBL] [Abstract][Full Text] [Related]
20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]